Bringing a new medicine to market typically takes well over a decade and costs an average of 2.2 billion dollars before approval.By the time the product launches, much of the patent term has already been used up and the window for recouping the investment is narrower than most teams expect.
For SMEs in pharma and biotech, the real payoff lies in the time spent alone on the market after launch, far more than in the number of patents held.
Fill out the form below to download the whitepaper.